ArticlePloS one2024

Correction: HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.

PLOS ONE StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.